ArticleCell reports. Medicine2026

Lipid-lowering and glucose-lowering drug targets differentially modulate antipsychotic treatment efficacy in schizophrenia.

Yunqing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.